午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频
上海一飛生物科技有限公司 Company Information
Company Name:
Shanghai Yifei Biotechnology Co. , Ltd.
Tel:
021-65675885
Email:
customer_service@efebio.com
Nationality:
China
WebSite:
http://www.efebio.com
Product List:
11974
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
Product List
PDK1-IN-RS2
1643958-89-7
Eptinezumab
1644539-04-7
HTL14242
1644645-32-8
DA-6886
1645260-76-9
Tomuzotuximab
1646321-00-7
FD-IN-1
1646682-14-5
BTA-9881
1646857-24-0
(R)-AZD 9639
1646857-28-4
Gimsilumab
1648796-29-5
Fremanezumab
1655501-53-3
NDB
1660153-08-1
Inotuzumab
1660159-36-3
BrBzGCp2
166038-00-2
(Rac)-Naxifylline
166181-76-6
CRT-0105950
1661845-86-8
Parthenosin
166196-16-3
Flotetuzumab
1664355-28-5
Timigutuzumab
1665274-14-5
AGN 192870
166977-57-7
Relatlimab
1673516-98-7
TGP-377/421
16752-89-9
Fluoroethylnormemantine
1639210-26-6
Delmetacin
16401-80-2
Lupartumab
1640971-88-5
TASP0390325
1642187-96-9
Leramistat
1642602-54-7
Zilovertamab
1643432-38-5
PW0464
1643462-93-4
SLMP53-1
1643469-17-3
Elsubrutinib
1643570-24-4
Frovocimab
1643672-70-1
Talastine
16188-61-7
Honokiol DCA
1620160-42-0
L-372662
162045-26-3
3-(Piperidin-4-yl)benzo[d]oxazol-2(3H)-one hydrochloride
162045-54-7
GNE-8505
1620573-48-9
Nav1.8-IN-4
1620846-16-3
GPR81 agonist 1
1620992-67-7
UCM-13207
1621536-10-4
Clivatuzumab
1622075-09-5
Selicrelumab
1622140-49-1
Laprituximab
1622327-38-1
Naratuximab
1622327-39-2
Glycopyrronium tosylate
1624259-25-1
Azido-PEG3-C6-Cl
1625717-44-3
hTYR/AbTYR-IN-1
1625821-37-5
Isolupalbigenin
162616-70-8
ABI-1968
1626364-18-8
(Rac)-Telinavir
162679-88-1
AC 7739
162705-22-8
JG-231
1627126-59-3
Rivabazumab
1627519-84-9
TAK-020
1627603-21-7
Nerelimomab
162774-06-3
CPL304110
1627826-19-0
FGFR4-IN-5
1628793-01-0
GBT1118
1628799-51-8
Vobarilizumab
1628814-88-9
Itacnosertib
1628870-27-8
KZR-504
1629052-78-3
Suptavumab
1629615-23-1
ALDH2 modulator 1
1629615-99-1
Suvratoxumab
1629620-18-3
Ladiratuzumab
1629760-28-6
BDBM50597431
1629853-49-1
(R)-DNMDP
1630760-60-9
Dapson-13C12
1632119-29-9
Ranevetmab
1632282-27-9
DHODH-IN-17
16344-26-6
Talviraline
163451-80-7
Aprutumab
1634620-63-5
Tavolixizumab
1635395-25-3
Ralaniten triacetate
1637573-04-6
GS-626510
1637770-13-8
DI-82
1638148-50-1
Osimertinib-d6
1638281-44-3
Otilimab
1638332-55-4
Navicixizumab
1638338-43-8
VU0453379
1638646-27-1
Vonlerolizumab
1638935-72-4
MAO-B-IN-8
1638956-60-1
Karavilagenin F
1639024-15-9
pan-HER-IN-2
1639040-95-1
UniPR129
1639159-47-9
Fluoroethylnormemantine hydrochloride
1639210-25-5
Cipepofol
1637741-58-2
URAT1 inhibitor 7
1632002-28-8
Dalzanemdor
1629853-48-0
Ibiglustat succinate
1629063-80-4
Gü2602
1627094-88-5
Zectivimod
1623066-63-6
TL4-12
1620820-12-3
ZEN-3694
1643947-30-1
Enrasentan
167256-08-8
CT-2584
166981-13-1
(Rac)-MEM 1003
165187-25-7
ACT-660602
1646267-59-5
TDRL-551
1644626-43-6
RS1-PDK1 inhibitor
1643958-85-3
MLK-IN-1
1627729-62-7
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
Copyright 2007© ChemicalBook. All rights reserved.